搜索临床试验以：ZN-A-1041 MAD Capecitabine 1000 mg/m2 Trastuzumab 8 mg/kg iv. First Cycle
总计8个结果
-
Royal Marsden NHS Foundation TrustHoffmann-La Roche; Professor Cunningham's Clinical Research Fund完全的
-
The Netherlands Cancer InstituteRoche Pharma AG; Borstkanker Onderzoek Groep主动，不招人
-
QuantumLeap Healthcare Collaborative招聘中乳腺癌 | 乳腺肿瘤 | 乳腺肿瘤 | HER2阳性乳腺癌 | 血管肉瘤 | 局部晚期乳腺癌 | HER2 阴性乳腺癌 | TNBC - 三阴性乳腺癌 | 激素受体阳性肿瘤 | 激素受体阴性肿瘤 | 早期乳腺癌美国